3rd Quarter - Report

DUTKO WORLDWIDE, LLC for GENZYME

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Monitor federal legislation related to health care IP issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & as it relates to comparative effectiveness research funding. America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
CECIL SWAMIDOSS —
KAREN TRAMONTANO —
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1260 (111th), H.R. 3200 (111th), H.R. 1548 (111th), S. 515 (111th), S. 610 (111th)

Health Issues HCR

Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & as it relates to comparative effectiveness research funding. America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
CECIL SWAMIDOSS —
KAREN TRAMONTANO —
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS)

Bills named: S. 610 (111th), S. 515 (111th), H.R. 3200 (111th), H.R. 1260 (111th), H.R. 1548 (111th)

Medicare/Medicaid MMM

Monitor federal legislation related to Medicare and other health care issues and advise client as it affects them. In addition, Patent Reform Act of 2009 (H.R.1260/ S.515/S.610), Budget resolution FY2010 (bill number has not yet been assigned), Pathway for Biosimilars Act (H.R. 1548), Physician Payments Sunshine Act of 2009 (S301) & as it relates to comparative effectiveness research funding. America's Affordable Health Choices Act of 2009 (H.R. 3200), Senate HELP Committee mark (no bill number assigned), Senate Finance Committee mark (no bill number assigned). Pharmaceutical import safety legislation.

LobbyistCovered position, as disclosed
CECIL SWAMIDOSS —
KAREN TRAMONTANO —
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Health & Human Services, Dept of (HHS)

Bills named: H.R. 1260 (111th), S. 515 (111th), S. 610 (111th), H.R. 1548 (111th), H.R. 3200 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.